Business Description
Clearmind Medicine Inc
NAICS : 541714
SIC : 3741
ISIN : CA1850534027
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 125.9 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -9.1 | |||||
3-Year EPS without NRI Growth Rate | -38.6 | |||||
3-Year FCF Growth Rate | -25.2 | |||||
3-Year Book Growth Rate | -59.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.75 | |||||
9-Day RSI | 60.26 | |||||
14-Day RSI | 59.86 | |||||
6-1 Month Momentum % | -2.01 | |||||
12-1 Month Momentum % | -70.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.71 | |||||
Quick Ratio | 1.71 | |||||
Cash Ratio | 1.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -205.2 | |||||
Shareholder Yield % | -12.46 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -189.11 | |||||
ROA % | -86.95 | |||||
ROIC % | -125.5 | |||||
3-Year ROIIC % | -141.83 | |||||
ROC (Joel Greenblatt) % | -12576.22 | |||||
ROCE % | -128.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.64 | |||||
Price-to-Tangible-Book | 1.76 | |||||
EV-to-EBIT | 0.33 | |||||
EV-to-EBITDA | 0.33 | |||||
EV-to-FCF | 0.64 | |||||
Price-to-Net-Current-Asset-Value | 1.81 | |||||
Price-to-Net-Cash | 1.99 | |||||
Earnings Yield (Greenblatt) % | 302.3 | |||||
FCF Yield % | -44.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Clearmind Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -4.255 | ||
Beta | 0 | ||
Volatility % | 88.25 | ||
14-Day RSI | 59.86 | ||
14-Day ATR (€) | 0.091552 | ||
20-Day SMA (€) | 1.2137 | ||
12-1 Month Momentum % | -70.19 | ||
52-Week Range (€) | 0.808 - 6.459 | ||
Shares Outstanding (Mil) | 4.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clearmind Medicine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clearmind Medicine Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Clearmind Medicine Inc Frequently Asked Questions
What is Clearmind Medicine Inc(STU:CWY0)'s stock price today?
When is next earnings date of Clearmind Medicine Inc(STU:CWY0)?
Does Clearmind Medicine Inc(STU:CWY0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |